13 Jan 2017

Yellow fever vaccine use: Annual Return advance notice for Yellow Fever Vaccination Centres (YFVC)

YFVC in England, Wales and Northern Ireland are reminded that the call for Annual Returns of yellow fever vaccine use will open in January 2017 Yellow fever vaccine use: Annual Return advance notice for Yellow Fever Vaccination Centres (YFVC)

Annual return of yellow fever vaccine use, 2016 (Designated centres only)
YFVC who ceased to be designated during 2016 do not need to submit this Annual Return, but will be asked to complete a separate survey in due course.

All Yellow Fever Vaccination Centres (YFVC), who remained designated during 2016, are reminded that the Annual Return (AR) of yellow fever must be submitted.  The AR is now open (see below) and can be accessed until 28 February 2017.

Important information about the Annual Return survey

The Annual Return can only be submitted electronically; The contact person for each centre will be sent important additional detail by email.
Being prepared should help to ensure you are able to submit helpful data.  Before going to the survey link, please familiarise yourself with the detail required for the return period (1 January 2016 to 31 December 2016).

The electronic return form consists of short questions, and can be completed very quickly if you have the following information to hand:

  • YFVC identifying number
  • Type of YFVC
  • Number of vaccines given (and where known, number given in specific age ranges)
  • Number of booster doses given and reasons for giving boosters
  • Number of serious adverse events reported to Medicines and Healthcare Products Regulatory Agency (MHRA)
  • Detail of serious adverse events reported
  • Number of yellow fever vaccine wasted
  • Reason for vaccine wastage

Your responses will help inform what is known about yellow fever vaccination practice in England, Wales and Northern Ireland.  All data will be anonymised and statistics from individual YFVCs will not be published. The provisional anonymised data from the collated annual returns will be published on the TravelHealthPro website.


Thank you.
Hilary Simons
On behalf of the Yellow Fever Strategic Review Group, NaTHNaC

Changes to the Country Information pages: Tick-borne encephalitis

NaTHNaC has reviewed and updated the tick-borne encephalitis country specific information in order to provide up-to-date recommendations for travellers and travel health professionals Read more

Viral Hepatitis update

WHO publishes the Global Hepatitis Report 2017 and the UK adds hepatitis B vaccination to its routine childhood immunisation schedule Read more

Measles in Europe

A reminder for travellers to be up to date with measles vaccine Read more

Legionnaires’ disease in Dubai

Legionnaires’ disease reported in travellers visiting Dubai Read more

Vaccines in the news: product shortages

Update on vaccine availability and risk assessment for pre-travel vaccination Read more
Back to Top

VIEW FULL INDEX